Impact of HSD11B1 Polymorphisms on BMI and Components of the Metabolic Syndrome in Patients Receiving Psychotropic Treatments
Pharmacogenetics and Genomics - United States
doi 10.1097/fpc.0000000000000131
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)